TSS
APVO icon

Two Sigma Securities’s Aptevo Therapeutics APVO Stock Holding History

Two Sigma Securities’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$5.04K – 1683
2024
Q3 		$5.04K Buy
+2
New +$9.21K ﹤0.01% 2668
2024
Q1 		– Hold
0
– -$2.04K – 2944
2023
Q4 		– Hold
0
– – – 2923
2023
Q1 		– Hold
0
– -$34.5K – 2627
2022
Q4 		– Hold
0
– – – 2208
2019
Q3 		– Hold
0
– -$13K – 2040
2019
Q2 		– Hold
0
– – – 1977
2019
Q1 		– Hold
0
– – – 1692
2018
Q1 		– Hold
0
– -$56K – 2655
2017
Q4 		– Hold
0
– – – 1512

Other funds holding APVO

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFFP
Center for Financial Planning Southfied, Michigan $1.07B AUM 18.98% 1-Year Est. Return

Two Sigma Securities's APVO Position: Q4 2024 in Review

Two Sigma Securities sold out of Aptevo Therapeutics (APVO) in Q4 2024, closing a stake of 2 shares — an estimated $5.04K sold.

Two Sigma Securities first reported a position in APVO in Q3 2024 and held it in 1 quarter. The position peaked at $5.04K in Q3 2024. 7 funds tracked by Wall St. Rank hold APVO as of Q4 2024.

  • Two Sigma Securities reported no remaining Aptevo Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 2 Aptevo Therapeutics shares in Q4 2024, an estimated $5.04K.
  • Two Sigma Securities first reported a position in Aptevo Therapeutics in Q3 2024 and held it in 1 quarter.
  • Two Sigma Securities's Aptevo Therapeutics position peaked at $5.04K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.